Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Shaoshuang Wang, Jianjun Huo, Yanlin Wei, Mei Huan, Zhouling Luo, Meihua Li, Mingzhi Wen, Xiaoning Zhong, Zhiyi He, Nan Ma, Jufeng Qiu & Xiaojuan Tang. (2022) Effect of erythromycin on the ultrastructure of human macrophages exposed to cigarette smoke extract in vitro. Ultrastructural Pathology 46:4, pages 303-312.
Read now
Read now
Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Read now
Yeonseok Choi, Sun Hye Shin, Hyun Lee, Hyun Kyu Cho, Yunjoo Im, Noeul Kang, Hye Sook Choi & Hye Yun Park. (2021) Favorable Response to Long-Term Azithromycin Therapy in Bronchiectasis Patients with Chronic Airflow Obstruction Compared to Chronic Obstructive Pulmonary Disease Patients without Bronchiectasis. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 855-863.
Read now
Read now
Mario Cazzola, Josuel Ora, Andrea Bianco, Paola Rogliani & Maria Gabriella Matera. (2021) Management of COPD patients during COVID: difficulties and experiences. Expert Review of Respiratory Medicine 15:8, pages 1025-1033.
Read now
Read now
Igor Z Barjaktarevic & Aaron P Milstone. (2020) Nebulized Therapies in COPD: Past, Present, and the Future. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1665-1677.
Read now
Read now
Articles from other publishers (27)
Federico Karp, Luciano N. Mengatto, Florencia S. Satler, Ludmila N. Turino, Diana A. Estenoz & Julio A. Luna. (2022) Antibiotic delivery based on poly(lactic-co-glycolic) acid and natural polymers: a biocomposite strategy. Iranian Polymer Journal 32:3, pages 299-312.
Crossref
Crossref
Gianluca Ciarlo, Jessica Rademacher & Gernot G. U. Rohde. (2022) Antibiotic Stewardship und chronische LungenerkrankungenAntibiotic stewardship and chronic lung diseases. Zeitschrift für Pneumologie 19:6, pages 369-377.
Crossref
Crossref
Dinesh K. Chellappan, Parteek Prasher, Shakti D. Shukla, Tong W. Yee, Tiong K. Kah, Toh W. Xyan, Tang W. Kid, Teoh H. Si, Ting S. Weng, Nagashekhara Molugulu, Lakshmana P. Sakthivel, Jestin Chellian, Thiagarajan Madheswaran, Himaja Malipeddi, Yogendra Singh, Harish Dureja, Deepak N. Kapoor, Poonam Negi, Rohit Goyal, Lakshmi Thangavelu, Deepak Kumar, Piyush K. Gupta, Niraj K. Jha, Madhur D. Shastri, Ronan MacLoughlin, Sachin K. Singh, Monica Gulati, Gaurav Gupta & Kamal Dua. (2022) Exploring the role of antibiotics and steroids in managing respiratory diseases. Journal of Biochemical and Molecular Toxicology 36:10.
Crossref
Crossref
Parvarish Sharma, Daljeet Singh Dhanjal, Chirag Chopra, Murtaza M. Tambuwala, Sukhwinder Singh Sohal, Peter J. van der Spek, Hari S. Sharma & Saurabh Satija. (2022) Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery. Chemico-Biological Interactions 365, pages 110050.
Crossref
Crossref
Tom D. Y. Reijnders, Hessel Peters-Sengers, Lonneke A. van Vught, Fabrice Uhel, Marc J. M. Bonten, Olaf L. Cremer, Marcus J. Schultz, Martijn M. Stuiver, Tom van der Poll, Friso M. de Beer, Lieuwe D. J. Bos, Gerie J. Glas, Roosmarijn T. M. van Hooijdonk, Janneke Horn, Laura R. A. Schouten, Marleen Straat, Luuk Wieske, Esther Witteveen, Tom D. Y. Reijnders, Alex R. Schuurman, Tjitske S. R. van Engelen, Liza Pereverzeva, Arie J. Hoogendijk, Mischa A. Huson, Maryse A. Wiewel, Peter M. C. Klein Klouwenberg, David S. Y. Ong, Jos F. Frencken, Maria E. Koster-Brouwer, Kirsten van de Groep & Diana M. Verboom. (2022) Effect of erythromycin on mortality and the host response in critically ill patients with sepsis: a target trial emulation. Critical Care 26:1.
Crossref
Crossref
J. Ancel, M. Guecamburu, V. Marques Da Silva, P. Schilfarth, L. Boyer, C. Pilette, C. Martin, P. Devillier, P. Berger, M. Zysman, O. Le Rouzic, J. Gonzalez-Bermejo, B. Degano, P.-R. Burgel, E. Ahmed, N. Roche & G. Deslee. (2022) Principaux messages de la première Biennale BPCO 2021 de la SPLF. Mieux comprendre pour innover. Revue des Maladies Respiratoires 39:5, pages 427-441.
Crossref
Crossref
Thais Beauperthuy, Amina Bekki & Miguel Ángel Martínez-García. (2022) Chronic bronchial infection in stable COPD: An under-recognized situation that needs attention. Respiratory Medicine and Research 81, pages 100894.
Crossref
Crossref
Jialiang Sun & Yanan Li. (2021) Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases. Pediatric Research 91:5, pages 1036-1042.
Crossref
Crossref
丽菊 梁. (2022) Efficacy and Safety of Azithromycin Combined with Cephalosporins in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Advances in Clinical Medicine 12:02, pages 1142-1152.
Crossref
Crossref
Siddhi Jain, Sneha Durugkar, Pritam Saha, Sharad B. Gokhale, V.G.M. Naidu & Pawan Sharma. (2022) Effects of intranasal azithromycin on features of cigarette smoke-induced lung inflammation. European Journal of Pharmacology 915, pages 174467.
Crossref
Crossref
Saurabh Satija, Daljeet Singh Dhanjal, Parvarish Sharma, Md Sadique Hussain, Yinghan Chan, Sin Wi Ng, Parteek Prasher, Harish Dureja, Chirag Chopra, Reena Singh, Gaurav Gupta, Dinesh Kumar Chellappan, Kamal Dua & Meenu Mehta. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
125
141
.
Jake R. Weeks, Karl J. Staples, C. Mirella Spalluto, Alastair Watson & Tom M. A. Wilkinson. (2021) The Role of Non-Typeable Haemophilus influenzae Biofilms in Chronic Obstructive Pulmonary Disease. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Nicolas Roche. (2021) Systemic Medications in Chronic Obstructive Pulmonary Disease. Thoracic Surgery Clinics 31:2, pages 97-106.
Crossref
Crossref
Ingrid Allart-Simon, Aurélie Moniot, Nicolo Bisi, Miguel Ponce-Vargas, Sandra Audonnet, Marie Laronze-Cochard, Janos Sapi, Eric Hénon, Frédéric Velard & Stéphane Gérard. (2021) Pyridazinone derivatives as potential anti-inflammatory agents: synthesis and biological evaluation as PDE4 inhibitors. RSC Medicinal Chemistry 12:4, pages 584-592.
Crossref
Crossref
Hikaru Tamura, Tomoki Maekawa, Hisanori Domon, Takumi Hiyoshi, Satoru Hirayama, Toshihito Isono, Karin Sasagawa, Daisuke Yonezawa, Naoki Takahashi, Masataka Oda, Takeyasu Maeda, Koichi Tabeta & Yutaka Terao. (2021) Effects of Erythromycin on Osteoclasts and Bone Resorption via DEL-1 Induction in Mice. Antibiotics 10:3, pages 312.
Crossref
Crossref
Rachana Mandru, Christine Y. Zhou, Rachel Pauley & Robert M. Burkes. (2021) Considerations for and Mechanisms of Adjunct Therapy in COPD. Journal of Clinical Medicine 10:6, pages 1225.
Crossref
Crossref
Sadia Janjua, Alexander G Mathioudakis, Rebecca Fortescue, Ruth AE Walker, Sahar Sharif, Christopher JD Threapleton & Sofia Dias. (2021) Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2021:1.
Crossref
Crossref
Raja Dhar, Deepak Talwar, Virendra Singh, Harjit Dumra, Sujeet Rajan & SK Jindal. (2021) Expert recommendations on the role of macrolides in chronic respiratory diseases. Lung India 38:2, pages 174.
Crossref
Crossref
Nicolas Roche. (2020) Systemic Medications in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 41:3, pages 485-494.
Crossref
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, A. V. Emel'yanov, I. V. Demko, G. L. Ignatova, I. N. Trofimenko & E. I. Shmelev. (2020) Inhalation glucocorticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 30:3, pages 330-343.
Crossref
Crossref
P.S. Shankar, K. Korukonda, S. Bendre, D. Behera, L. Mirchandani, N.T. Awad, R. Prasad, S. Bhargava, O.P. Sharma & S.K. Jindal. (2020) Diagnoses and management of adult cough: An Indian Environmental Medical Association (EMA) position paper. Respiratory Medicine 168, pages 105949.
Crossref
Crossref
Edward J M Monk, Chris Harris, Rainer Döffinger, Gemma Hayes, David W Denning & Chris Kosmidis. (2020) Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all-cause hospital admission. Thorax 75:6, pages 513-516.
Crossref
Crossref
Olivier Le Rouzic. (2020) Prise en charge de la broncho-pneumopathie chronique obstructive (BPCO) en 2020. La Presse Médicale Formation 1:2, pages 141-150.
Crossref
Crossref
José Luis Lopez-Campos, Marc Miravitlles, David de la Rosa Carrillo, Rafael Cantón, Juan Jose Soler-Cataluña & Miguel Angel Martinez-Garcia. (2020) Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 9:6, pages 1639.
Crossref
Crossref
Kentaro Akata & Stephan F. van Eeden. (2020) Lung Macrophage Functional Properties in Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences 21:3, pages 853.
Crossref
Crossref
Stephan F. van Eeden & James C. Hogg. (2020) Immune-Modulation in Chronic Obstructive Pulmonary Disease: Current Concepts and Future Strategies. Respiration 99:7, pages 550-565.
Crossref
Crossref
Xue-Jiao Sun & Zhi-Yi He. (2019) Macrolides for treatment of chronic obstructive pulmonary disease. Chinese Medical Journal 132:11, pages 1261-1263.
Crossref
Crossref